Key Facts

Invested since 2010
Based in Lower Saxony

About the company

IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.

Do you want to

know more about this company?

Zum Artikel

Dr. Jan Engels Investment Manager

Dr. Jan EngelsInvestment Manager

Implandata Ophthalmic Products in the news

Zum Artikel

Press

30. January 2012

1.4 million series A financing of Implandata Ophthalmic Products GmbH: new kind of diagnosis tool for glaucoma therapy shortly before market launch

Zum Artikel

Press

21. June 2010

High tech for eye patients: start-up team develops a new kind of diagnosis tool for glaucoma therapy

More startups from Life Sciences